News
AFib screening cuts hospitalizations and ED visits
May 11, 2019
NEW ORLEANS – People diagnosed with atrial fibrillation by screening had fewer hospitalizations and ED visits than those diagnosed by usual care.
News
SGLT2 inhibitors prevent HF hospitalization regardless of baseline LVEF
May 9, 2019
NEW ORLEANS – “At least in my mind, we have more than enough evidence at this point to say that SGLT2 inhibitors are effective in preventing heart failure,” Dr. Mikhail Kosiborod said.
News
Quick Byte: Hope for HF patients
May 8, 2019
Device shows promise for heart failure patients.
News
The search for a life-changing innovation
May 7, 2019
A new book documents the decades-long pursuit of an artificial heart.
News
Single-center study outlines stroke risk, DOAC type in nonvalvular AFib patients
May 6, 2019
PHILADELPHIA –Rivaroxaban was more often than other DOACs associated with events in nonvalvular atrial fibrillation patients, based on a small study from a tertiary care center in Australia.
News
Long-term antibiotic use may heighten stroke, CHD risk
April 28, 2019
Among middle-aged and older women, 2 or more months’ exposure to antibiotics is associated with an increased likelihood of cardiovascular disease.
News
Epinephrine linked with more refractory cardiogenic shock after acute MI
April 18, 2019
Is there a difference in safety and efficacy when using epinephrine versus norepinephrine for cardiogenic shock after successful reperfusion in acute myocardial infarction (AMI)?
News
Poor response to statins hikes risk of cardiovascular events
April 17, 2019
Patients with better outcomes were more likely to have initiated therapy with a more potent drug.
News
Statin exposure associated with idiopathic inflammatory myositis
April 15, 2019
What is the association between exposure to statin medications and histologically confirmed idiopathic inflammatory myositis?
News
PIONEER-HF Extension: Don’t stall starting sacubitril/valsartan
April 14, 2019
NEW ORLEANS – “The early improvement in postdischarge outcomes supports the in-hospital initiation of sacubitril/valsartan.” – Dr. Adam D. DeVore